, /PRNewswire/ -- InSilicoTrials (IST) is honored to have received the AI Startup of the Year award at Startup Grind Global 2024 in Silicon Valley, . IST won amidst intense competition from 650 startups and was one of only 142 selected to present and demonstrate their innovations. The key factors that led to IST's win were the platform's proven efficiency outcomes (aligned with global regulatory bodies' guidelines), the substantial savings in R&D costs, and the extended market exclusivity period it generates.
On behalf of InSilicoTrials, both CEO and COO were present at the event. presented IST's transformative solutions, showcasing the platform's impact on healthcare innovation. engaged with other industry leaders to discuss the broader implications of AI in the healthcare sector today.
IST's commitment to regulatory science was highlighted by its contribution to the open-access book - published by Springer Nature. The book features a foreword by the U.S.
Food and Drug Administration and is co-edited by CEO . This recognition, which has also been featured in - celebrates IST's innovative use of advanced artificial intelligence in healthcare. The Forbes article, titled " " underlines the dynamic tech environment of the Bay Area.
CEO was quoted: , Global Partnerships Manager at Startup Grind, highlighted InSilicoTrials' win, stating, "We are thrilled to announce that InSilicoTrials has been honored as the AI Startup of the Year at the Startup Grind Global Conference! Emerging .
